Reports suggest that biotechnology company Elan Corp Plc has received first-round bids for its drug delivery unit Elan Drug Technologies (EDT), with private equity firms TPG Capital and Bain Capital thought to be potential buyers. The sale is hoped to fetch between USD 1.3bn and USD 1.4bn.
Charcoal and natural additives company saw final bids from two banks and one direct lender
VCs including the Swiss Entrepreneurs Fund, BtoV and Ringier Digital Ventures also participated
Around 40 existing and new LPs, including British Patient Capital and the EIF, participated
Fund will invest in buyouts, recapitalisations and carve-outs of both profitable and underperforming businesses